Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thyroid Neoplasms | 36 | 2023 | 2274 | 5.520 |
Why?
|
Telomerase | 8 | 2023 | 729 | 1.730 |
Why?
|
Proto-Oncogene Proteins B-raf | 11 | 2023 | 2028 | 1.650 |
Why?
|
Adenocarcinoma, Follicular | 4 | 2021 | 324 | 1.110 |
Why?
|
Carcinoma, Papillary | 6 | 2023 | 781 | 0.860 |
Why?
|
Promoter Regions, Genetic | 8 | 2020 | 5867 | 0.720 |
Why?
|
Mutation | 18 | 2023 | 29717 | 0.690 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2023 | 2938 | 0.640 |
Why?
|
Proto-Oncogenes | 1 | 2019 | 321 | 0.630 |
Why?
|
Adenocarcinoma | 2 | 2023 | 6347 | 0.530 |
Why?
|
TOR Serine-Threonine Kinases | 4 | 2021 | 2107 | 0.510 |
Why?
|
Paired Box Transcription Factors | 1 | 2013 | 215 | 0.430 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2502 | 0.420 |
Why?
|
Carcinoma | 4 | 2023 | 2374 | 0.420 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2019 | 2948 | 0.400 |
Why?
|
Thyroid Nodule | 3 | 2023 | 750 | 0.390 |
Why?
|
Epistasis, Genetic | 1 | 2013 | 365 | 0.380 |
Why?
|
Genetic Predisposition to Disease | 10 | 2016 | 17400 | 0.360 |
Why?
|
Upstream Stimulatory Factors | 1 | 2009 | 20 | 0.360 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2010 | 60 | 0.360 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2010 | 322 | 0.340 |
Why?
|
Forkhead Transcription Factors | 3 | 2013 | 1613 | 0.330 |
Why?
|
Genes, ras | 3 | 2017 | 691 | 0.320 |
Why?
|
Paraganglioma | 5 | 2010 | 143 | 0.320 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2013 | 1158 | 0.310 |
Why?
|
Eukaryotic Initiation Factor-1 | 2 | 2018 | 33 | 0.310 |
Why?
|
Pheochromocytoma | 4 | 2011 | 337 | 0.300 |
Why?
|
Genetic Association Studies | 3 | 2016 | 2699 | 0.280 |
Why?
|
Spain | 6 | 2015 | 465 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2018 | 8425 | 0.220 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3564 | 0.220 |
Why?
|
Prognosis | 8 | 2023 | 29010 | 0.210 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2023 | 1659 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-ret | 4 | 2013 | 220 | 0.210 |
Why?
|
Cell Line, Tumor | 10 | 2022 | 16665 | 0.210 |
Why?
|
ras Proteins | 2 | 2018 | 1060 | 0.200 |
Why?
|
Adrenal Gland Neoplasms | 4 | 2011 | 740 | 0.200 |
Why?
|
Germ-Line Mutation | 7 | 2021 | 1786 | 0.190 |
Why?
|
RNA, Messenger | 4 | 2015 | 13029 | 0.180 |
Why?
|
Succinate Dehydrogenase | 3 | 2010 | 146 | 0.180 |
Why?
|
Polymorphism, Single Nucleotide | 11 | 2016 | 15494 | 0.180 |
Why?
|
ADP-Ribosylation Factors | 1 | 2019 | 133 | 0.170 |
Why?
|
Humans | 50 | 2023 | 742088 | 0.170 |
Why?
|
Oncogene Proteins | 1 | 2023 | 749 | 0.170 |
Why?
|
Validation Studies as Topic | 1 | 2019 | 159 | 0.160 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2021 | 3585 | 0.160 |
Why?
|
Activating Transcription Factor 4 | 1 | 2018 | 81 | 0.160 |
Why?
|
Carcinoma, Medullary | 2 | 2010 | 123 | 0.160 |
Why?
|
Golgi Apparatus | 1 | 2019 | 410 | 0.160 |
Why?
|
Signal Transduction | 7 | 2023 | 23387 | 0.160 |
Why?
|
Tubulin | 2 | 2012 | 695 | 0.150 |
Why?
|
Mediator Complex | 1 | 2017 | 109 | 0.140 |
Why?
|
Symporters | 1 | 2019 | 363 | 0.140 |
Why?
|
Thyroid Gland | 3 | 2019 | 1172 | 0.140 |
Why?
|
Iodine Radioisotopes | 1 | 2019 | 1030 | 0.140 |
Why?
|
Gene Deletion | 2 | 2015 | 2751 | 0.130 |
Why?
|
Immunophenotyping | 1 | 2020 | 1866 | 0.130 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 890 | 0.120 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2015 | 287 | 0.120 |
Why?
|
Neurofibromin 2 | 1 | 2015 | 267 | 0.120 |
Why?
|
Up-Regulation | 1 | 2023 | 4211 | 0.120 |
Why?
|
Genetic Variation | 1 | 2009 | 6540 | 0.120 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2015 | 380 | 0.120 |
Why?
|
Paclitaxel | 2 | 2012 | 1707 | 0.120 |
Why?
|
DNA Transposable Elements | 1 | 2017 | 748 | 0.110 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 814 | 0.110 |
Why?
|
Biopsy, Fine-Needle | 3 | 2023 | 1093 | 0.110 |
Why?
|
Alternative Splicing | 1 | 2018 | 1118 | 0.110 |
Why?
|
Mutagenesis | 1 | 2017 | 1263 | 0.110 |
Why?
|
Mice, Transgenic | 4 | 2019 | 9735 | 0.110 |
Why?
|
Cytochrome P-450 CYP3A | 2 | 2010 | 115 | 0.110 |
Why?
|
Models, Genetic | 2 | 2013 | 3493 | 0.100 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2010 | 290 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1811 | 0.100 |
Why?
|
Tumor Burden | 1 | 2017 | 1905 | 0.100 |
Why?
|
Mice | 9 | 2023 | 81045 | 0.100 |
Why?
|
Middle Aged | 21 | 2021 | 213127 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1683 | 0.100 |
Why?
|
Jaw Neoplasms | 1 | 2011 | 70 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1581 | 0.090 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2012 | 325 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2015 | 1284 | 0.090 |
Why?
|
Male | 23 | 2022 | 349538 | 0.090 |
Why?
|
Gene Silencing | 2 | 2013 | 1538 | 0.090 |
Why?
|
Genomics | 2 | 2023 | 5692 | 0.090 |
Why?
|
Animals | 10 | 2023 | 168561 | 0.090 |
Why?
|
Female | 24 | 2021 | 379592 | 0.090 |
Why?
|
Disease Progression | 2 | 2019 | 13256 | 0.090 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2019 | 2455 | 0.090 |
Why?
|
Genes, Neoplasm | 1 | 2011 | 376 | 0.090 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2011 | 155 | 0.090 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4187 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6534 | 0.080 |
Why?
|
Adult | 19 | 2021 | 213712 | 0.080 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2011 | 314 | 0.080 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2009 | 106 | 0.080 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2010 | 257 | 0.080 |
Why?
|
Case-Control Studies | 5 | 2022 | 21719 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1899 | 0.080 |
Why?
|
Polymerase Chain Reaction | 4 | 2011 | 6171 | 0.080 |
Why?
|
Exons | 2 | 2011 | 2431 | 0.080 |
Why?
|
Gene Dosage | 2 | 2010 | 1251 | 0.080 |
Why?
|
Aged, 80 and over | 10 | 2021 | 57683 | 0.080 |
Why?
|
Iron-Sulfur Proteins | 1 | 2007 | 82 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 544 | 0.070 |
Why?
|
Loss of Heterozygosity | 3 | 2018 | 678 | 0.070 |
Why?
|
Microtubules | 1 | 2012 | 1090 | 0.070 |
Why?
|
Genotype | 4 | 2020 | 12946 | 0.070 |
Why?
|
Neurotoxicity Syndromes | 1 | 2010 | 290 | 0.070 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2010 | 623 | 0.070 |
Why?
|
Alleles | 3 | 2015 | 6931 | 0.070 |
Why?
|
Young Adult | 10 | 2021 | 56350 | 0.070 |
Why?
|
Chromatin | 1 | 2017 | 2917 | 0.070 |
Why?
|
MicroRNAs | 1 | 2021 | 3731 | 0.070 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2007 | 241 | 0.060 |
Why?
|
Cell Line | 1 | 2019 | 15994 | 0.060 |
Why?
|
Binding Sites | 2 | 2015 | 6115 | 0.060 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2007 | 419 | 0.060 |
Why?
|
Cell Death | 1 | 2010 | 1695 | 0.060 |
Why?
|
Polymorphism, Genetic | 3 | 2010 | 4328 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12344 | 0.060 |
Why?
|
Aged | 15 | 2021 | 162944 | 0.060 |
Why?
|
Thrombocytopenia | 1 | 2012 | 1171 | 0.060 |
Why?
|
Genome-Wide Association Study | 2 | 2015 | 12220 | 0.060 |
Why?
|
MAP Kinase Signaling System | 1 | 2011 | 1525 | 0.060 |
Why?
|
Base Sequence | 3 | 2011 | 12797 | 0.060 |
Why?
|
Molecular Sequence Data | 3 | 2015 | 18112 | 0.060 |
Why?
|
Sequence Deletion | 1 | 2007 | 1526 | 0.060 |
Why?
|
Risk Assessment | 2 | 2022 | 23320 | 0.050 |
Why?
|
Genome, Human | 1 | 2016 | 4420 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18006 | 0.050 |
Why?
|
Neoplasm Proteins | 2 | 2017 | 3691 | 0.050 |
Why?
|
Haplotypes | 4 | 2010 | 2781 | 0.050 |
Why?
|
Protein Binding | 2 | 2015 | 9387 | 0.050 |
Why?
|
Retrospective Studies | 7 | 2023 | 77098 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2019 | 9410 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2011 | 2842 | 0.050 |
Why?
|
Cell Proliferation | 4 | 2019 | 10472 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5851 | 0.050 |
Why?
|
Oncogenes | 2 | 2017 | 1263 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 4751 | 0.040 |
Why?
|
Neoplasms | 4 | 2015 | 21596 | 0.040 |
Why?
|
Ribonuclease III | 1 | 2021 | 275 | 0.040 |
Why?
|
Ultrasonography | 2 | 2023 | 5978 | 0.040 |
Why?
|
Prostate | 1 | 2007 | 1764 | 0.040 |
Why?
|
DEAD-box RNA Helicases | 1 | 2021 | 375 | 0.040 |
Why?
|
von Hippel-Lindau Disease | 2 | 2010 | 152 | 0.040 |
Why?
|
Haploidy | 1 | 2018 | 136 | 0.040 |
Why?
|
Founder Effect | 2 | 2009 | 190 | 0.040 |
Why?
|
Membrane Proteins | 2 | 2020 | 7873 | 0.040 |
Why?
|
Adolescent | 10 | 2021 | 85649 | 0.040 |
Why?
|
GTP Phosphohydrolases | 1 | 2020 | 508 | 0.040 |
Why?
|
Lactic Acid | 1 | 2022 | 1132 | 0.040 |
Why?
|
Protein Isoforms | 2 | 2012 | 1727 | 0.030 |
Why?
|
Position-Specific Scoring Matrices | 1 | 2015 | 11 | 0.030 |
Why?
|
Genetic Testing | 1 | 2009 | 3439 | 0.030 |
Why?
|
Necrosis | 1 | 2020 | 1643 | 0.030 |
Why?
|
Transcription Factors | 1 | 2015 | 12164 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 3 | 2018 | 5522 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15530 | 0.030 |
Why?
|
Gene Order | 1 | 2015 | 176 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2015 | 2940 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2019 | 2335 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2013 | 19862 | 0.030 |
Why?
|
Risk Factors | 2 | 2013 | 72145 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2019 | 2085 | 0.030 |
Why?
|
Mitosis | 1 | 2020 | 1208 | 0.030 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2015 | 351 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1875 | 0.030 |
Why?
|
Carbanilides | 1 | 2013 | 17 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2015 | 677 | 0.030 |
Why?
|
Lymphocytes | 1 | 2022 | 2614 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2013 | 3504 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2022 | 1175 | 0.030 |
Why?
|
Watchful Waiting | 1 | 2017 | 491 | 0.030 |
Why?
|
Molecular Weight | 1 | 2015 | 2255 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2715 | 0.030 |
Why?
|
Benzoxazoles | 1 | 2013 | 78 | 0.030 |
Why?
|
Introns | 1 | 2015 | 991 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1107 | 0.030 |
Why?
|
Gene Targeting | 1 | 2015 | 880 | 0.030 |
Why?
|
Uniparental Disomy | 1 | 2011 | 43 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 732 | 0.020 |
Why?
|
RNA Polymerase II | 1 | 2015 | 550 | 0.020 |
Why?
|
Child | 6 | 2021 | 77478 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 2018 | 2126 | 0.020 |
Why?
|
Lysine | 1 | 2015 | 1008 | 0.020 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2011 | 154 | 0.020 |
Why?
|
Isoenzymes | 1 | 2015 | 1725 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2015 | 1400 | 0.020 |
Why?
|
Inheritance Patterns | 1 | 2012 | 340 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 6313 | 0.020 |
Why?
|
Breast | 1 | 2019 | 1958 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3557 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4391 | 0.020 |
Why?
|
Parathyroid Neoplasms | 1 | 2011 | 245 | 0.020 |
Why?
|
Cell Membrane | 1 | 2019 | 3744 | 0.020 |
Why?
|
Apoptosis | 2 | 2018 | 9715 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4839 | 0.020 |
Why?
|
Neutrophils | 1 | 2022 | 3711 | 0.020 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 1 | 2009 | 44 | 0.020 |
Why?
|
Genes, erbB-1 | 1 | 2010 | 161 | 0.020 |
Why?
|
Adenoma | 2 | 2011 | 2168 | 0.020 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2010 | 321 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2015 | 1782 | 0.020 |
Why?
|
DNA Repair | 1 | 2018 | 2042 | 0.020 |
Why?
|
Dioxygenases | 1 | 2010 | 316 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3847 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2012 | 11363 | 0.020 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2009 | 768 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2007 | 65 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1655 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 53187 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2015 | 11001 | 0.020 |
Why?
|
Phosphorylation | 1 | 2018 | 8436 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12773 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 1940 | 0.020 |
Why?
|
Population Surveillance | 1 | 2017 | 2616 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2011 | 2837 | 0.020 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 627 | 0.020 |
Why?
|
Aneuploidy | 1 | 2010 | 530 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4200 | 0.020 |
Why?
|
Penetrance | 1 | 2007 | 380 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2713 | 0.020 |
Why?
|
Gene Amplification | 1 | 2010 | 1062 | 0.020 |
Why?
|
Histones | 1 | 2015 | 2597 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 2003 | 0.020 |
Why?
|
Syndrome | 1 | 2011 | 3248 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 40955 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 1114 | 0.020 |
Why?
|
Glycoproteins | 1 | 2012 | 2260 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2007 | 11039 | 0.020 |
Why?
|
Body Mass Index | 1 | 2022 | 12695 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2015 | 3444 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 2638 | 0.010 |
Why?
|
Point Mutation | 1 | 2009 | 1624 | 0.010 |
Why?
|
Prostatic Hyperplasia | 1 | 2007 | 522 | 0.010 |
Why?
|
Neuroblastoma | 1 | 2011 | 1225 | 0.010 |
Why?
|
DNA Primers | 1 | 2007 | 2892 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16331 | 0.010 |
Why?
|
Age of Onset | 1 | 2009 | 3266 | 0.010 |
Why?
|
Antigens, CD | 1 | 2012 | 4024 | 0.010 |
Why?
|
Pyrimidines | 1 | 2013 | 2933 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5163 | 0.010 |
Why?
|
Peptides | 1 | 2012 | 4392 | 0.010 |
Why?
|
Down-Regulation | 1 | 2007 | 3001 | 0.010 |
Why?
|
Pituitary Neoplasms | 1 | 2008 | 1340 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2011 | 13814 | 0.010 |
Why?
|
Models, Biological | 1 | 2015 | 9581 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 40450 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 62966 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2007 | 7721 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20774 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2011 | 39004 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13655 | 0.010 |
Why?
|